• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s diseaseChristos Andronis2018-09-05T12:24:45+00:00
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s. Explore the mechanism of action of GLP-1/GIP dual agonists in Alzheimer’s with Biovista Vizit.

Explore the live graph.

Tags: ALZHEIMER'S DISEASE, CELL DEATH, CELL DIFFERENTIATION, DIABETES, EXENATIDE, GIP, GLP-1, INFLAMMATORY RESPONSE, LIPID METABOLIC PROCESS, LIRAGLUTIDE, METFORMIN, NEURON DEATH, SAXAGLIPTIN, SITAGLIPTIN PHOSPHATE

Post navigation

← Mitochondrial role in Cancer Metastasis
Alzheimer’s and Olfactory impairment →

Vizit Graphs Tag Cloud

CELL PROLIFERATION CLOSTRIDIUM DIFFICILE 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE AGING METFORMIN CANDIDA ALBICANS CANCER CTLA4 APOPTOTIC PROCESS PARKINSON DISEASE RECEPTOR REMICADE RHEUMATOID ARTHRITIS STREPTOCOCCUS PNEUMONIAE CASP3 DIABETES MELLITUS IMMUNE RESPONSE CELL DIFFERENTIATION ALZHEIMER'S DISEASE ESCHERICHIA COLI IL17A CELL DEATH INSULIN PORPHYROMONAS GINGIVALIS ERBB-2 BREAST CANCER HELICOBACTER PYLORI LISTERIA MONOCYTOGENES NEURODEGENERATIVE DISORDERS SOD1 AUTOPHAGY TNF DOXORUBICIN CD4 FOXP3 STAPHYLOCOCCUS AUREUS INFLAMMATION TH17 CELLS CELL DIVISION ANGIOGENESIS PSEUDOMONAS AERUGINOSA IL6 IL23A TP53 IFNG

© 2019 Biovista Vizit All Rights Reserved.